TrialDiabetic medicine : a journal of the British Diabetic Association2016

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.

E Franek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.